Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 145

1.

The aging signature: a hallmark of induced pluripotent stem cells?

Rohani L, Johnson AA, Arnold A, Stolzing A.

Aging Cell. 2014 Feb;13(1):2-7. doi: 10.1111/acel.12182. Epub 2013 Nov 21. Review.

2.

Rejuvenating senescent and centenarian human cells by reprogramming through the pluripotent state.

Lapasset L, Milhavet O, Prieur A, Besnard E, Babled A, Aït-Hamou N, Leschik J, Pellestor F, Ramirez JM, De Vos J, Lehmann S, Lemaitre JM.

Genes Dev. 2011 Nov 1;25(21):2248-53. doi: 10.1101/gad.173922.111.

3.

The senescence-related mitochondrial/oxidative stress pathway is repressed in human induced pluripotent stem cells.

Prigione A, Fauler B, Lurz R, Lehrach H, Adjaye J.

Stem Cells. 2010 Apr;28(4):721-33. doi: 10.1002/stem.404.

4.

Mitochondrial-associated cell death mechanisms are reset to an embryonic-like state in aged donor-derived iPS cells harboring chromosomal aberrations.

Prigione A, Hossini AM, Lichtner B, Serin A, Fauler B, Megges M, Lurz R, Lehrach H, Makrantonaki E, Zouboulis CC, Adjaye J.

PLoS One. 2011;6(11):e27352. doi: 10.1371/journal.pone.0027352. Epub 2011 Nov 14.

5.

mTOR-regulated senescence and autophagy during reprogramming of somatic cells to pluripotency: a roadmap from energy metabolism to stem cell renewal and aging.

Menendez JA, Vellon L, Oliveras-Ferraros C, Cufí S, Vazquez-Martin A.

Cell Cycle. 2011 Nov 1;10(21):3658-77. doi: 10.4161/cc.10.21.18128. Epub 2011 Nov 1. Review.

PMID:
22052357
6.

Enhanced telomere rejuvenation in pluripotent cells reprogrammed via nuclear transfer relative to induced pluripotent stem cells.

Le R, Kou Z, Jiang Y, Li M, Huang B, Liu W, Li H, Kou X, He W, Rudolph KL, Ju Z, Gao S.

Cell Stem Cell. 2014 Jan 2;14(1):27-39. doi: 10.1016/j.stem.2013.11.005. Epub 2013 Nov 21.

7.

The Epigenetic Reprogramming Roadmap in Generation of iPSCs from Somatic Cells.

Brix J, Zhou Y, Luo Y.

J Genet Genomics. 2015 Dec 20;42(12):661-70. doi: 10.1016/j.jgg.2015.10.001. Epub 2015 Oct 23. Review.

PMID:
26743984
8.

Molecular insights into the heterogeneity of telomere reprogramming in induced pluripotent stem cells.

Wang F, Yin Y, Ye X, Liu K, Zhu H, Wang L, Chiourea M, Okuka M, Ji G, Dan J, Zuo B, Li M, Zhang Q, Liu N, Chen L, Pan X, Gagos S, Keefe DL, Liu L.

Cell Res. 2012 Apr;22(4):757-68. doi: 10.1038/cr.2011.201. Epub 2011 Dec 20.

9.

Mitochondrial resetting and metabolic reprogramming in induced pluripotent stem cells and mitochondrial disease modeling.

Hsu YC, Chen CT, Wei YH.

Biochim Biophys Acta. 2016 Apr;1860(4):686-93. doi: 10.1016/j.bbagen.2016.01.009. Epub 2016 Jan 15. Review.

PMID:
26779594
10.

Role of tumor suppressor genes in the cancer-associated reprogramming of human induced pluripotent stem cells.

Lin YC, Murayama Y, Hashimoto K, Nakamura Y, Lin CS, Yokoyama KK, Saito S.

Stem Cell Res Ther. 2014;5(2):58. Review.

11.

Analysis of human and mouse reprogramming of somatic cells to induced pluripotent stem cells. What is in the plate?

Boué S, Paramonov I, Barrero MJ, Izpisúa Belmonte JC.

PLoS One. 2010 Sep 17;5(9). pii: e12664. doi: 10.1371/journal.pone.0012664.

12.

Reactivation of the inactive X chromosome and post-transcriptional reprogramming of Xist in iPSCs.

Kim JS, Choi HW, Araúzo-Bravo MJ, Schöler HR, Do JT.

J Cell Sci. 2015 Jan 1;128(1):81-7. doi: 10.1242/jcs.154294. Epub 2014 Nov 6.

13.

Mitochondrial and metabolic remodeling during reprogramming and differentiation of the reprogrammed cells.

Choi HW, Kim JH, Chung MK, Hong YJ, Jang HS, Seo BJ, Jung TH, Kim JS, Chung HM, Byun SJ, Han SG, Seo HG, Do JT.

Stem Cells Dev. 2015 Jun 1;24(11):1366-73. doi: 10.1089/scd.2014.0561. Epub 2015 Apr 2.

PMID:
25590788
14.

MicroRNAs contribute to induced pluripotent stem cell somatic donor memory.

Vitaloni M, Pulecio J, Bilic J, Kuebler B, Laricchia-Robbio L, Izpisua Belmonte JC.

J Biol Chem. 2014 Jan 24;289(4):2084-98. doi: 10.1074/jbc.M113.538702. Epub 2013 Dec 5.

15.

A novel model of urinary tract differentiation, tissue regeneration, and disease: reprogramming human prostate and bladder cells into induced pluripotent stem cells.

Moad M, Pal D, Hepburn AC, Williamson SC, Wilson L, Lako M, Armstrong L, Hayward SW, Franco OE, Cates JM, Fordham SE, Przyborski S, Carr-Wilkinson J, Robson CN, Heer R.

Eur Urol. 2013 Nov;64(5):753-61. doi: 10.1016/j.eururo.2013.03.054. Epub 2013 Apr 6.

16.

Epigenetic memory in induced pluripotent stem cells.

Kim K, Doi A, Wen B, Ng K, Zhao R, Cahan P, Kim J, Aryee MJ, Ji H, Ehrlich LI, Yabuuchi A, Takeuchi A, Cunniff KC, Hongguang H, McKinney-Freeman S, Naveiras O, Yoon TJ, Irizarry RA, Jung N, Seita J, Hanna J, Murakami P, Jaenisch R, Weissleder R, Orkin SH, Weissman IL, Feinberg AP, Daley GQ.

Nature. 2010 Sep 16;467(7313):285-90. doi: 10.1038/nature09342.

17.

Programming and Reprogramming Cellular Age in the Era of Induced Pluripotency.

Studer L, Vera E, Cornacchia D.

Cell Stem Cell. 2015 Jun 4;16(6):591-600. doi: 10.1016/j.stem.2015.05.004. Review.

18.

Hotspots of aberrant epigenomic reprogramming in human induced pluripotent stem cells.

Lister R, Pelizzola M, Kida YS, Hawkins RD, Nery JR, Hon G, Antosiewicz-Bourget J, O'Malley R, Castanon R, Klugman S, Downes M, Yu R, Stewart R, Ren B, Thomson JA, Evans RM, Ecker JR.

Nature. 2011 Mar 3;471(7336):68-73. doi: 10.1038/nature09798. Epub 2011 Feb 2. Erratum in: Nature. 2014 Oct 2;514(7520):126.

19.

Aging and reprogramming: a two-way street.

Mahmoudi S, Brunet A.

Curr Opin Cell Biol. 2012 Dec;24(6):744-56. doi: 10.1016/j.ceb.2012.10.004. Epub 2012 Nov 9. Review.

20.

Reliable generation of induced pluripotent stem cells from human lymphoblastoid cell lines.

Barrett R, Ornelas L, Yeager N, Mandefro B, Sahabian A, Lenaeus L, Targan SR, Svendsen CN, Sareen D.

Stem Cells Transl Med. 2014 Dec;3(12):1429-34. doi: 10.5966/sctm.2014-0121. Epub 2014 Oct 8.

Supplemental Content

Support Center